Literature DB >> 27194296

AMPK Negatively Regulates Peripheral Myelination via Activation of c-Jun.

Xiaoyu Liu1, Su Peng1, Yahong Zhao1, Tingting Zhao1, Meihong Wang1, Lan Luo2, Yumin Yang3, Cheng Sun4.   

Abstract

The process of Schwann cells (SCs) forming a sheath around axons is termed as myelination, which plays a pivotal role for proper physiological function in the peripheral nervous system (PNS). The molecular mechanisms regulating SC myelination in the PNS remain to be elucidated. Here, we show that AMP-activated protein kinase (AMPK) in sciatic nerves was gradually decreased during the PNS myelination process. Pharmacological interventions showed that activation of AMPK by AICAR attenuated myelin gene expression in SCs, whereas inhibition of AMPK by Compound C (ComC) or AMPKα1 knockdown stimulated myelin gene expression. Following experiments revealed that c-Jun, a negative modulator of PNS myelination, was activated by AMPK in SCs. The application of ComC in newborn rats markedly downregulated c-Jun expression in sciatic nerves. The lipid and protein synthesis in sciatic nerves was greatly potentiated by ComC. As a consequence, myelin gene expression in sciatic nerves, as well as myelin sheath thickness, were promoted in the ComC-treated rats. All together, our data identify that AMPK is an important negative regulator of Schwann cell myelination in the PNS, and this regulation role may rely on c-Jun activation.

Entities:  

Keywords:  AICAR; AMPK; Compound C; Myelination; Schwann cells; c-Jun

Mesh:

Substances:

Year:  2016        PMID: 27194296     DOI: 10.1007/s12035-016-9913-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  33 in total

Review 1.  The mammalian Jun proteins: redundancy and specificity.

Authors:  F Mechta-Grigoriou; D Gerald; M Yaniv
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

2.  The tumour suppressor LKB1 regulates myelination through mitochondrial metabolism.

Authors:  Shabnam Pooya; Xiaona Liu; V B Sameer Kumar; Jane Anderson; Fumiyasu Imai; Wujuan Zhang; Georgianne Ciraolo; Nancy Ratner; Kenneth D R Setchell; Yutaka Yoshida; Yoshida Yutaka; Michael P Jankowski; Biplab Dasgupta
Journal:  Nat Commun       Date:  2014-09-26       Impact factor: 14.919

3.  mTORC1 controls PNS myelination along the mTORC1-RXRγ-SREBP-lipid biosynthesis axis in Schwann cells.

Authors:  Camilla Norrmén; Gianluca Figlia; Frédéric Lebrun-Julien; Jorge A Pereira; Martin Trötzmüller; Harald C Köfeler; Ville Rantanen; Carsten Wessig; Anne-Lieke F van Deijk; August B Smit; Mark H G Verheijen; Markus A Rüegg; Michael N Hall; Ueli Suter
Journal:  Cell Rep       Date:  2014-10-09       Impact factor: 9.423

Review 4.  AMPK: a nutrient and energy sensor that maintains energy homeostasis.

Authors:  D Grahame Hardie; Fiona A Ross; Simon A Hawley
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-22       Impact factor: 94.444

5.  Myelination in rat brain: method of myelin isolation.

Authors:  W T Norton; S E Poduslo
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

6.  The protective effects of resveratrol on Schwann cells with toxicity induced by ethanol in vitro.

Authors:  Hongtu Yuan; Jingfen Zhang; Huaxiang Liu; Zhenzhong Li
Journal:  Neurochem Int       Date:  2013-06-13       Impact factor: 3.921

7.  Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination.

Authors:  S Priyadarshini Narayanan; Ana I Flores; Feng Wang; Wendy B Macklin
Journal:  J Neurosci       Date:  2009-05-27       Impact factor: 6.167

Review 8.  Negative regulation of myelination: relevance for development, injury, and demyelinating disease.

Authors:  Kristján R Jessen; Rhona Mirsky
Journal:  Glia       Date:  2008-11-01       Impact factor: 8.073

Review 9.  AMPK, insulin resistance, and the metabolic syndrome.

Authors:  Neil B Ruderman; David Carling; Marc Prentki; José M Cacicedo
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

10.  c-Jun is a negative regulator of myelination.

Authors:  David B Parkinson; Ambily Bhaskaran; Peter Arthur-Farraj; Luke A Noon; Ashwin Woodhoo; Alison C Lloyd; M Laura Feltri; Lawrence Wrabetz; Axel Behrens; Rhona Mirsky; Kristján R Jessen
Journal:  J Cell Biol       Date:  2008-05-19       Impact factor: 10.539

View more
  3 in total

1.  Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis in Parkinson's disease models both in vitro and in vivo.

Authors:  Su Peng; Caiping Wang; Jinyu Ma; Ketao Jiang; Yuhui Jiang; Xiaosong Gu; Cheng Sun
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

Review 2.  Molecular Mechanisms Involved in Schwann Cell Plasticity.

Authors:  Angélique Boerboom; Valérie Dion; Alain Chariot; Rachelle Franzen
Journal:  Front Mol Neurosci       Date:  2017-02-17       Impact factor: 5.639

3.  Analysis of Signal Transduction Pathways Downstream M2 Receptor Activation: Effects on Schwann Cell Migration and Morphology.

Authors:  Elisabetta Botticelli; Michael Sebastian Salazar Intriago; Roberta Piovesana; Ada Maria Tata
Journal:  Life (Basel)       Date:  2022-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.